Companies

Sponsors developing CNS drugs — 58 companies across 108compounds in development, with mechanism, indication, and phase for each.35 publicly traded.

• Neurocrine Biosciences, Inc.
  NBIXUnited States
  6 compounds2 Phase 3+
• Alto Neuroscience, Inc.
  ANROUnited States
  5 compounds
• Axsome Therapeutics, Inc.
  AXSMUnited States
  4 compounds4 Phase 3+
• Biohaven Ltd.
  BHVNUnited States
  4 compounds1 Phase 3+
• Cerevel Therapeutics Holdings, Inc.
  PrivateUnited States
  4 compounds1 Phase 3+
• Johnson & Johnson
  JNJUnited States
  4 compounds1 Phase 3+
• Merck & Co., Inc.
  MRKUnited States
  4 compounds
• Otsuka Pharmaceutical Co., Ltd.
  4578.TJapan
  4 compounds2 Phase 3+
• Taisho Pharmaceutical Co., Ltd.
  PrivateJapan
  4 compounds1 Phase 3+
• Alkermes plc
  ALKSIreland
  3 compounds3 Phase 3+
• Boehringer Ingelheim International GmbH
  PrivateGermany
  3 compounds
• Intra-Cellular Therapies, Inc.
  ITCIUnited States
  3 compounds1 Phase 3+
• Vanda Pharmaceuticals Inc.
  VNDAUnited States
  3 compounds3 Phase 3+
• Aelis Farma S.A.
  AELISFrance
  2 compounds
• Beckley Psytech Limited
  ATAIUnited Kingdom
  2 compounds
• Cortexyme, Inc. (now Quince Therapeutics, Inc.)
  QNCXUnited States
  2 compounds
• Definium Therapeutics, Inc.
  DFTXUnited States
  2 compounds1 Phase 3+
• Gilgamesh Pharmaceuticals, Inc.
  PrivateUnited States
  2 compounds
• Helus Pharma
  HELPCanada
  2 compounds1 Phase 3+
• Neumora Therapeutics, Inc.
  NMRAUnited States
  2 compounds
• Relmada Therapeutics, Inc.
  RLMDUnited States
  2 compounds
• Syndeio Biosciences, Inc.
  PrivateUnited States
  2 compounds
• Takeda Pharmaceutical Company Limited
  4502.TJapan
  2 compounds1 Phase 3+
• Teva Pharmaceutical Industries Ltd.
  TEVAIsrael
  2 compounds1 Phase 3+
• Tonix Pharmaceuticals Holding Corp.
  TNXPUnited States
  2 compounds1 Phase 3+
• ACADIA Pharmaceuticals Inc.
  ACADUnited States
  1 compound1 Phase 3+
• AegisCN LLC
  PrivateUnited States
  1 compound
• Atai Beckley N.V. (AtaiBeckley)
  ATAIUnited States
  1 compound
• Autobahn Therapeutics, Inc.
  PrivateUnited States
  1 compound
• BioXcel Therapeutics, Inc.
  BTAIUnited States
  1 compound1 Phase 3+
• COMPASS Pathways plc
  CMPSUnited Kingdom
  1 compound1 Phase 3+
• CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
  1093.HKChina
  1 compound1 Phase 3+
• Delix Therapeutics, Inc.
  PrivateUnited States
  1 compound
• Draig Therapeutics Ltd
  PrivateUnited Kingdom
  1 compound
• Emalex Biosciences Inc.
  PrivateUnited States
  1 compound1 Phase 3+
• EmpathBio, Inc.
  ATAIUnited States
  1 compound
• Engrail Therapeutics, Inc.
  PrivateUnited States
  1 compound
• GH Research PLC
  GHRSIreland
  1 compound
• Hoffmann-La Roche
  Switzerland
  1 compound
• Ionis Pharmaceuticals, Inc.
  IONSUnited States
  1 compound1 Phase 3+
• LB Pharmaceuticals Inc.
  LBRXUnited States
  1 compound1 Phase 3+
• Lipocine Inc.
  LPCNUnited States
  1 compound1 Phase 3+
• MapLight Therapeutics, Inc.
  MPLTUnited States
  1 compound
• Mindset Pharma Inc.
  PrivateCanada
  1 compound
• Minerva Neurosciences, Inc.
  NERVUnited States
  1 compound1 Phase 3+
• Mitsubishi Tanabe Pharma Corporation
  PrivateJapan
  1 compound
• Navitor Pharmaceuticals, Inc.
  PrivateUnited States
  1 compound
• Neuphoria Therapeutics, Inc.
  NEUPAustralia
  1 compound
• Pherin Pharmaceuticals, Inc.
  PrivateUnited States
  1 compound
• Reunion Neuroscience Inc.
  PrivateUnited States
  1 compound
• Reviva Pharmaceuticals Holdings, Inc.
  RVPHUnited States
  1 compound1 Phase 3+
• Sanofi
  SNYFrance
  1 compound
• Seaport Therapeutics, Inc.
  SPTXUnited States
  1 compound
• Sirtsei Pharmaceuticals, Inc.
  PrivateUnited States
  1 compound
• Suven Life Sciences Limited
  SUVENIndia
  1 compound
• Transcend Therapeutics, Inc.
  PrivateUnited States
  1 compound1 Phase 3+
• Vistagen Therapeutics, Inc.
  VTGNUnited States
  1 compound1 Phase 3+
• Xenon Pharmaceuticals Inc.
  XENECanada
  1 compound1 Phase 3+